Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.
Kroon ED, Ungsedhapand C, Ruxrungtham K, Chuenyam M, Ubolyam S, Newell ME, van Leeuwen R, Kunanusont C, Buranapraditkul S, Sirivichayakul S, Lange JM, Cooper DA, Phanuphak P. Kroon ED, et al. Among authors: sirivichayakul s. AIDS. 2000 Jul 7;14(10):1349-56. doi: 10.1097/00002030-200007070-00007. AIDS. 2000. PMID: 10930149 Clinical Trial.
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.
Phanuphak P, Grayson ML, Sirivichayakul S, Suwanagool S, Ruxrungtham K, Hanvanich M, Ratanasuwan W, Ubolyam S, Hughes MD, Wanke CA, Hammer SM. Phanuphak P, et al. Among authors: sirivichayakul s. Aust N Z J Med. 2000 Feb;30(1):11-20. doi: 10.1111/j.1445-5994.2000.tb01048.x. Aust N Z J Med. 2000. PMID: 10800872 Clinical Trial.
Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD); TREAT Asia Studies to Evaluate Resistance (TASER). Kiertiburanakul S, et al. J Int AIDS Soc. 2014 Mar 14;17(1):18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014. J Int AIDS Soc. 2014. PMID: 24598459 Free PMC article.
AIDS at a university hospital in Bangkok, Thailand.
Ruxrungtham K, Muller O, Sirivichayakul S, Ubolyam S, Teeratakulpisarn S, Hanvanich M, Phanuphak P. Ruxrungtham K, et al. Among authors: sirivichayakul s. AIDS. 1996 Aug;10(9):1047-9. doi: 10.1097/00002030-199610090-00021. AIDS. 1996. PMID: 8853744 No abstract available.
HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, Phanuphak P, Merati T, Ratanasuwan W, Lee CK, Ditangco R, Mustafa M, Singtoroj T, Kiertiburanakul S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M). Jiamsakul A, et al. J Int AIDS Soc. 2014 Aug 19;17(1):19053. doi: 10.7448/IAS.17.1.19053. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25141905 Free PMC article.
135 results